We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.07B
AUM Growth
+$73.4M
Cap. Flow
-$4.19M
Cap. Flow %
-0.39%
Top 10 Hldgs %
69.02%
Holding
69
New
1
Increased
16
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$2M
2
VHT icon
Vanguard Health Care ETF
VHT
+$711K
3
BMY icon
Bristol-Myers Squibb
BMY
+$635K
4
JKHY icon
Jack Henry & Associates
JKHY
+$610K
5
PSX icon
Phillips 66
PSX
+$485K

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$6.14M
2
WFC icon
Wells Fargo
WFC
+$3.71M
3
BNY
Bank of New York Mellon
BNY
+$851K
4
KHC icon
Kraft Heinz
KHC
+$420K
5
BAC icon
Bank of America
BAC
+$91.1K

Sector Composition

Rank Sector Weight
1 Financials 45.24%
2 Healthcare 19.86%
3 Materials 6.83%
4 Industrials 6.41%
5 Technology 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRU icon
51
Prudential Financial
PRU
$42.2B
$687K 0.06%
6,350
– –
MET icon
52
MetLife
MET
$61.5B
$661K 0.06%
10,580
– –
VEEV icon
53
Veeva Systems
VEEV
$38.4B
$511K 0.05%
2,000
– –
KHC icon
54
Kraft Heinz
KHC
$29.2B
$508K 0.05%
14,150
-11,700
-45% -$420K
ECL icon
55
Ecolab
ECL
$79.8B
$493K 0.05%
2,100
– –
VZ icon
56
Verizon
VZ
$196B
$488K 0.05%
9,400
– –
ASHR icon
57
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$457K 0.04%
11,700
– –
ALPN
58
DELISTED
Alpine Immune Sciences Inc
ALPN
$145K 0.01%
10,445
– –
AKTX
59
Akari Therapeutics
AKTX
$13.5M
$135K 0.01%
112
– –
OCUL icon
60
Ocular Therapeutix
OCUL
$2.14B
$84K 0.01%
+12,000
New +$93.2K
ALDX icon
61
Aldeyra Therapeutics
ALDX
$91.1M
$80K 0.01%
20,020
– –
BDSI
62
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$78K 0.01%
25,000
– –
CRVS icon
63
Corvus Pharmaceuticals
CRVS
$1.24B
$48K ﹤0.01%
19,959
– –
ADMA icon
64
ADMA Biologics
ADMA
$2.22B
– –
-30,075
Closed -$34K
AMRN
65
Amarin Corp
AMRN
$296M
– –
-750
Closed -$77K
BUD icon
66
AB InBev
BUD
$159B
– –
-108,860
Closed -$6.14M
1 2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q4 2021 Portfolio in Review

As of Q4 2021, Hikari Power held 69 positions worth $1.07B, up 7.4% from $997M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Hikari Power's Q4 2021 filing shows 1 new, 16 increased, 4 reduced and 3 closed positions. Its largest new stake was Ocular Therapeutix: 12,000 shares worth $84K. The largest sale was AB InBev, an estimated $6.14M.

By sector, the portfolio is most concentrated in Financials at 45% of assets, down from 46% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power's largest Q4 2021 buy was Ocular Therapeutix: 12,000 shares worth $84K.
  • Hikari Power added most to Altria Group in Q4 2021, an estimated $2M increase.
  • Hikari Power's biggest Q4 2021 reduction was Wells Fargo, cutting an estimated $3.71M.
  • Hikari Power fully exited AB InBev in Q4 2021, selling an estimated $6.14M.
  • Hikari Power's ten largest holdings make up 69% of its $1.07B portfolio in Q4 2021.
  • Hikari Power opened 1 new position and closed 3 in Q4 2021.
  • Hikari Power's portfolio value rose 7.4% quarter-over-quarter to $1.07B.

Based on Hikari Power's 13F filing for Q4 2021, filed 12 Jan 2022.